Synchronous BRAF(V600E) and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity - Gadiot, J; Hooijkaas, A I; Deken, M A (Onco Targets Ther, 2013)
et al.